Mitch K. Goldenberg
Chief Tech/Sci/R&D Officer at CONCERT PHARMACEUTICALS, INC.
Network origin in Mitch K. Goldenberg first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Private Company | Pharmaceuticals: Major | 32 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mitch K. Goldenberg via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| XENOPORT, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| Dartmouth College | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| CITIGROUP INC. | Major Banks | Corporate Officer/Principal Corporate Officer/Principal | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Boston University | College/University | Graduate Degree Undergraduate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Babson College | College/University | Undergraduate Degree Masters Business Admin | |
| ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Faraday Pharmaceuticals, Inc. (Washington)
 Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA. | Drugstore Chains | Corporate Officer/Principal Corporate Officer/Principal | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Undergraduate Degree | |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bourn Hall LLC
 Bourn Hall LLC Hospital/Nursing ManagementHealth Services Bourn Hall LLC offers fertility treatment programs. It offers assisted reproductive technology, genetic testing and gender balancing, men's health, gynecology surgeries, fertility preservation, cosmetic gynecology, female fertility treatments, male fertility treatments, and Platelet Rich Plasma. The company was founded in 2012 and is headquartered in Dubai, the United Arab Emirates. | Hospital/Nursing Management | Chairman | |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
TVM Capital Healthcare Partners Ltd. /SG/
 TVM Capital Healthcare Partners Ltd. /SG/ Investment ManagersFinance Tvm Capital Healthcare Partners Pte Ltd. operates as a healthcare private equity investor. The company is headquartered in Singapore. | Investment Managers | Chief Executive Officer | |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The BioExec Institute, Inc. is a network of executives in the life sciences industry. The private company is based in Cambridge, MA. The company was founded in 2004 by Hoda Jeanne Abou-Jamra. Hoda Jeanne Abou-Jamra has been the CEO since 2004. | Miscellaneous Commercial Services | Director/Board Member | |
| The Reed Institute | College/University | Undergraduate Degree | |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Director/Board Member | |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment ManagersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Investment Managers | Analyst-Equity | |
Aptiv Services US LLC
 Aptiv Services US LLC Auto Parts: OEMProducer Manufacturing Aptiv Services US LLC manufactures automotive components. The firm provides such as chassis, engine steering, thermal, controls & security systems, electrical/electronic architecture, in-car entertainment technologies and electrical products. The company is headquartered in Troy, MI. | Auto Parts: OEM | Corporate Officer/Principal | |
| University of South Carolina | College/University | Undergraduate Degree | |
| Darla Moore School of Business | College/University | Masters Business Admin | |
Medikine, Inc.
 Medikine, Inc. Pharmaceuticals: MajorHealth Technology Medikine, Inc. is a privately held biopharmaceutical company located in an undisclosed location. The American company's mission is to transform the discovery of oncology, autoimmune disorder, and infectious disease therapeutics by employing a versatile drug discovery platform that generates modular "peptikines." These peptikines are peptide mimetics of cytokines that are smaller in molecular size than, and structurally unrelated to, the natural cytokines they emulate. Medikine's lead candidate, mdk-703, is currently in a phase 1 clinical trial in healthy volunteers. Ronald W. Barrett has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Wisconsin | College/University | Doctorate Degree | |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO | |
| ENGENE HOLDINGS INC. | Biotechnology | Director of Finance/CFO | |
Quadriga BioSciences, Inc.
 Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
Robert W. Baird & Co., Inc.
 Robert W. Baird & Co., Inc. Investment ManagersFinance Robert W. Baird & Co., Inc. operates as a wealth management, capital markets, private equity and asset management firm. It offers equity research, corporate restructuring, mergers and acquisitions, public financing and fixed income services. The firm serves individual, corporate, institutional and municipal clients. The company was founded by Robert Wilson Baird in 1919 and is headquartered in Milwaukee, WI. | Investment Managers | Corporate Officer/Principal | |
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
| Bucknell University | College/University | Undergraduate Degree | |
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Biotechnology | Director/Board Member | |
| AMECO MEDICAL INDUSTRIES | Medical Specialties | Director/Board Member | |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Chairman | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| DERMATA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CRINETICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Patara Pharma LLC
 Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| Parke-Davis Pharmaceutical Research, Inc. | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 38 |
| United Kingdom | 4 |
| Austria | 3 |
| Germany | 3 |
| Israel | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 11 |
| Finance | 7 |
| Commercial Services | 5 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 125 |
| Corporate Officer/Principal | 78 |
| Independent Dir/Board Member | 42 |
| Undergraduate Degree | 25 |
| Chairman | 21 |
Most connected contacts
| Insiders | |
|---|---|
| Douglas Cole | 44 |
| John Freund | 37 |
| Meghan Fitzgerald | 28 |
| Helmut Schühsler | 28 |
| Wendell Wierenga | 23 |
| Jesper Høiland | 13 |
| Jeffrey S. Williams | 11 |
| Nancy Stuart | 10 |
| Christine van Heek | 9 |
| Thomas Auchincloss | 9 |
| Marc A. Becker | 9 |
| Ryan Daws | 9 |
| Ronald Barrett | 9 |
| Ian Robert Silverman | 8 |
| Justine E. Koenigsberg | 7 |
- Stock Market
- Insiders
- Mitch K. Goldenberg
- Company connections
